Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-02-03FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)
FDA approved a supplemental application for BINOSTO (alendronate sodium) submitted by Radius Health, Inc. The approval concerns an update to…
-
FDA approval · 2026-02-03FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Fosamax Plus D (alendronate sodium and cholecalciferol) submitted by Organon LLC.
-
FDA approval · 2026-02-03FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s supplemental application for ALENDRONATE SODIUM, indicating an approved change under the ANDA …
-
FDA approval · 2026-02-03FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Apotex Corp)
FDA approved Apotex Corp's supplemental application for ibandronate sodium, granting approval of a generic version. Ibandronate is used to t…
-
FDA approval · 2026-02-03FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for ibandronate sodium filed by Apotex Corp., under ANDA 204222.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-02-03FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Ibandronate Sodium submitted by Mylan Institutional LLC.
-
FDA approval · 2026-02-03FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ibandronate sodium submitted by Aurobindo Pharma Limited, confirming regulatory approval for thi…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy Subjects [Phase 1]
Phase 1 trial comparing pharmacokinetics, pharmacodynamics, safety, and immunogenicity of SAL023 versus Italy-manufactured Evenity in health…
-
EMA approval · 2026-01-30EMA Authorised: Osvyrti (denosumab) — Accord Healthcare S.L.U.
The EMA authorised Osvyrti, a denosumab product from Accord Healthcare S.L.U., for bone resorption disorders including osteoporosis and post…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL) [NA]
Clinical trial update for the VITAL study assessing how vitamin D and vitamin K interactions, with omega-3s, affect bone density, bone healt…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Metabolic Syndrome and Vitamin D Level in Old People
A completed clinical trial assessing the relationship between metabolic syndrome and vitamin D status in elderly participants.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Outcomes of Severe Osteoporotic Fractures Hospitalized in France: the CROSS Cohort
This clinical trial update reports on the CROSS cohort, evaluating outcomes of severe osteoporotic fragility fractures requiring hospitaliza…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Image-guided Computational and Experimental Analyses of Fractured Patient's Bone (GAP)
This Clinical Trial Update describes NCT04787679, a study on image-guided computational and experimental analyses of fractured bone in patie…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: OsteoPorotic fracTure preventION System (OPTIONS) Research Study [NA]
This document reports that the OPTIONS Osteoporotic Fracture Prevention System research study is currently recruiting.
-
EMA approval · 2026-01-28EMA Authorised: Forsteo (teriparatide) — Eli Lilly Nederland B.V.
The European Medicines Agency authorised Forsteo (teriparatide) for osteoporosis, including postmenopausal osteoporosis.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Senolytics to Improve Osteoporosis Therapy [Phase 2]
Phase 2 clinical trial update investigating senolytics to enhance osteoporosis therapy; current status is ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD [NA]
A completed clinical trial investigating CT-based modeling of bone micro-architecture and fracture risk in patients with chronic obstructive…
-
EMA approval · 2026-01-27EMA Authorised: Optruma (raloxifene hydrochloride) — Eli Lilly Nederland B.V.
The EMA authorised Optruma (raloxifene hydrochloride) from Eli Lilly Nederland B.V. for osteoporosis in postmenopausal women.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Effect of Wii Fit Balance Board Games on Balance in Patients With Osteoporosis Post Mastectomy [NA]
A completed clinical trial evaluated whether Wii Fit balance board games improve balance in patients with osteoporosis following mastectomy.…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Study on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes [NA]
This clinical trial evaluates denosumab for high-risk patients with osteoporosis and type 2 diabetes to assess its effect on fractures; the …
-
EMA approval · 2026-01-20EMA Authorised: Ponlimsi (denosumab) — Teva GmbH
The EMA authorised Ponlimsi (denosumab) by Teva GmbH on 19 January 2026 for osteoporosis, including postmenopausal osteoporosis.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Cortical Bone Assessment Using Ultrasonic Guided Waves: Towards a Robust Clinical Measurement
The trial update reports completion of a study evaluating ultrasonic guided waves for assessing cortical bone to improve clinical measuremen…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Prevention of Injury in Skilled Nursing Facilities Through Optimizing Medications [NA]
Duke University is conducting a clinical trial enrolling by invitation to prevent injuries in skilled nursing facilities by optimizing medic…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Validating Osteoporosis Detection in Rho AI Software [NA]
A completed clinical trial validating osteoporosis detection using the Rho AI software, focusing on osteopenia or osteoporosis conditions.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy [NA]
A Benha University-led trial is recruiting to assess whether Pilates exercises can improve bone mineral density in breast cancer survivors r…